Home » How Do We Improve the Path to New Medicine?

How Do We Improve the Path to New Medicine?

Three leading medical specialists provide their inside take on the state of clinical trials, from the public misconceptions to the modern realities to the benefits sown by the remarkable few who volunteer.

Joan Chambers

Joan Chambers, Chief Operating Officer, CenterWatch

"As clinical trials are important to society overall, the patients who volunteer and participate are equally important."

Ken Somberg

Ken Somberg, Chief Medical Officer, Covance

"All clinical trials are reviewed before they start by a team of independent physicians and scientists…"

Clare Grace

Clare Grace, VP of Site and Patient Access, INC Research

"Though the patient may not immediately benefit from participation, they can be confident that their efforts could benefit others."

<< previous article

Fighting Alzheimer’s: An Update from the Frontlines

next article >>

Addressing the Need for Alzheimer’s Research